Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

3 Investments to Consider as China’s Market Heats Up

Chinese stocks may be poised for further growth this year: these individual stocks and China-focused ETFs may be worth a closer look.

MarketBeat

Samsara Stock Plunges, But Technicals Flash a Buy Signal

Samsara is down 45% despite strong earnings and bullish ratings. An RSI of 18 suggests extreme oversold conditions, making this a rare buying opportunity.

MarketBeat

3 Retail Giants React to Tariffs—What It Means for Consumers

The Trump Tariffs have gone into effect with 25% import tariffs on Canada and Mexico and another 10% on China. Here's what the CEOs of top retailers are saying.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Rockwell Automation Poised to Gain From U.S. Tariffs & Onshoring

Rockwell Automation supplies industrial automation products like robots to factories and stands to benefit from the onshoring effects of the Trump Tariffs.

MarketBeat

3 Companies Buying Back Stock—Why It Matters

These insiders have been buying back stock lately, meaning their stock prices might be lower today, posing additional upside potential.

MarketBeat

Institutions Bought 3 Stocks Heavily in Q1 2025

Institutional activity shifted in Q3, reverting to buying in tech stocks like Apple, Crowdstrike, and Advanced Micro Devices with healthy cash flow.

MarketBeat

Beyond a Market Correction, Moves to Make Now

Even experienced investors can get shaken by sudden market corrections, before you consider your next move, here are some important things to consider

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

3 Dividend Picks Standing Strong as Bond Yields Fall

Falling bond yields might create a rotation into these attractive dividend stocks as relative yields become preferential for investors.

MarketBeat

NVIDIA Stock Remains Stunningly Undervalued—Here’s Why

NVIDIA is on track to hit new highs this year, but they may not come until the second half, after policy-related fears have died down.

MarketBeat

Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy

Oracle's position in the cloud and AI was cemented in F2025, positioning the company to accelerate its growth over the next two years.

MarketBeat

U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave

China, emerging markets, and Europe have outperformed the U.S. in 2025, with China’s FXI ETF up 18%, EEM up 4%, and IEV up 13% YTD.

MarketBeat

Joby Aviation: From Prototype to Profitability

Joby Aviation's air taxi vision takes flight, solidifying market leadership through certification strength, funding and operational gains.

MarketBeat

Marvell’s 40% Drop Presents a Compelling Buying Opportunity

AI-driven chip stock Marvell is down in the dumps to start 2025. Is now the time to get in, or wait for the dust in the market to settle?

MarketBeat

These 3 Dividend Stocks Jumped 15% in a Month—More to Come?

Dividend stocks aren't just for long-term income generation. These three shares have jumped 15% in one month while also offering dividend payouts.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Tesla Stock Is Oversold - Is Now the Time to Be Brave?

Tesla is down 55% from its high, but analysts still see 150% upside. In addition, an RSI of 20 suggests extreme oversold conditions.

MarketBeat

3 Stocks Institutions Are Quietly Dumping

Institutions have been selling out of discretionary consumer names lately, signaling a loss of confidence in the underlying economy and spending.

MarketBeat

Moderna: 4 Key Reasons the CEO Just Bought $5M in Shares

Moderna stock has fallen to levels not seen in 5 years, but the CEO just spent $5 million buying stock in the open market underscoring his optimism for gains.

MarketBeat

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

5 ETFs Poised to Spring Ahead in the Second Quarter

Here are five thematic ETFs that appear to be ideal for the current market conditions; each fund is delivering strong performance with low fees

MarketBeat

3 Stocks With Sky-High Buyback Yields Over the Last 12 Months

Check out these three stocks that have bought back shares big-time over the past 12 months, resulting in buyback yields of 10% or more.

MarketBeat

Top 3 Utilities Stocks Powering Up as Recession Fears Rise

Three utilities firms may stand out to investors seeking a refuge amid concerns about an impending recession, although each has a different profile.

MarketBeat

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Uncover five promising stocks under $10, each poised for gains across diverse sectors for the second quarter of 2025.

MarketBeat

Costco Price Plunge Equals Opportunity for Investors

Costco continues to take share from its competitors as it leads the industry in growth. Analysts are lifting their stock price targets, leading to new highs.

MarketBeat

3 Stocks Investing $650 Billion in the U.S.—Should You Invest?

See which three large-cap stocks are planning to invest a total of over $650 billion in the United States over the next several years.

MarketBeat

Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors

Novo Nordisk slashed prices on its GLP-1 obesity drugs as it launches NovoCare to gain compounded GLP-1 users as the compounding labs face deadlines to cease.

1 … 23 24 25 26

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.